As of May 2024 Verona Pharma has a market cap of $1.21 Billion. This makes Verona Pharma the world's 4901th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.21 B | -23.54% |
2023 | $1.58 B | -19.58% |
2022 | $1.97 B | 390% |
2021 | $0.40 B | -0.52% |
2020 | $0.40 B | 435.5% |
2019 | $75.7 M | -40.41% |
2018 | $0.12 B | -18.47% |
2017 | $0.15 B | 301.92% |
2016 | $38.77 M | -9.87% |
2015 | $43.01 M | 128.04% |
2014 | $18.86 M | |
2012 | $20.35 M | |
2008 | $8.24 M |
On May 4th, 2024 the market cap of Verona Pharma was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $18.25 M | -98.50% | Bahamas |
NRC Health
NRC | $0.83 B | -31.50% | ๐บ๐ธ USA |